Indivior Pharmaceuticals (INDV) Non-Current Debt (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted Non-Current Debt of $487 million for Q2 2026, up 58.1% from $308 million a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Non-Current Debt (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals' Non-Current Debt came in at $290 million, down 7.9% from FY2024.
- Annual Non-Current Debt shows a four-year compound annual growth rate of 5.0% (FY2021 to FY2025).
- In prior years, Indivior Pharmaceuticals' Non-Current Debt was $315 million in FY2024 (+32.9%), $237 million in FY2023 (unchanged), $237 million in FY2022 (-0.8%) and $239 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Non-Current Debt in data going back to Q4 2021.
- On a year-over-year basis, Non-Current Debt increased in three of the last four quarters, with growth averaging 34.8%.
- According to Business Quant data, Non-Current Debt for the three prior quarters was $486 million (Q1 2026), $290 million (Q4 2025) and $304 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Indivior Pharmaceuticals | 4.35 Bn | 3.32 Bn | 294.00 Mn | 487.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 487.00 Mn |
| Mar 31, 2026 | 486.00 Mn |
| Dec 31, 2025 | 290.00 Mn |
| Sep 30, 2025 | 304.00 Mn |
| Jun 30, 2025 | 308.00 Mn |
| Mar 31, 2025 | 311.00 Mn |
| Dec 31, 2024 | 315.00 Mn |
| Dec 31, 2023 | 237.00 Mn |
| Dec 31, 2022 | 237.00 Mn |
| Dec 31, 2021 | 239.00 Mn |
API Access
Indivior Pharmaceuticals Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();